Albert Schatz (scientist)
From Wikipedia, the free encyclopedia
Albert Schatz (2 February 1920 – 17 January 2005) was a scientist who was eventually named the co-discoverer of streptomycin, an antibiotic remedy used to treat tuberculosis and a number of other diseases. Schatz managed to isolate two strains of Actinobacteria, which could effectively cease the growth of several penicillin-resistant bacteria, on October 19, 1943 in the course of his graduate work at Cook College in Rutgers University.
Originally, the discovery of streptomycin was credited only to Schatz's supervisor, Selman Waksman. Schatz, however, strongly contested this, and in 1950 brought litigation against Waksman, requesting recognition as streptomycin's co-discoverer and a portion of streptomycin royalties. Schatz's requests were eventually granted in an out-of-court settlement.
Schatz was awarded the Rutgers medal in 1994 for his work on developing streptomycin.
Up until two years before his death, Schatz had worked for a local Co-op sharpening knives. He died from pancreatic cancer at his home in Philadelphia in 2005.
[edit] External links
- The Official Website for Albert Schatz, Ph. D.
- The Guardian article on Albert Schatz
- Memoirs at Rutgers Oral History Archives
- Schatz on fluoridation
- Weavers Way Co-op.
- San Diego Union-Tribune obituary
- Rutgers Focus obituary
- Streptomycin, Schatz v. Waksman, and the Balance of Credit for Discovery
 This biographical article related to medicine in the United States is a stub. You can help Wikipedia by expanding it. |
